MM-501 Domestic Opportunity in Heavily Pretreated Multiple Myeloma Not Eligible for Hospital-Based Treatment: Role of Pomalidomide-Dexamethasone.
Clinical lymphoma myeloma & leukemia/Clinical lymphoma, myeloma and leukemia(2022)
摘要
Pomalidomide-dexamethasone has shown significant efficacy and a very good compliance, thanks to oral administration, in a particularly severe setting of heavily pretreated patients, relapsed and refractory to all available therapeutic resources, also after failure of novel agents.
更多查看译文
关键词
pomalidomide,multiple myeloma,relapsed,refractory,pegfilgrastim
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要